Safety and Tolerability of M254 in Healthy Volunteers and Immune Thrombocytopenic Purpura (ITP) Patients

  • STATUS
    Recruiting
  • End date
    Jun 2, 2022
  • participants needed
    70
  • sponsor
    Momenta Pharmaceuticals, Inc.
Updated on 15 August 2021
Investigator
The Medical Research Network, LLC
Primary Contact
Momenta Investigational Site (0.0 mi away) Contact
+29 other location
igiv
immune globulin

Summary

The purpose of this study is to assess safety, tolerability, pharmacokinetics, and pharmacodynamics of M254 after administration of a single ascending dose and repeat doses in healthy volunteers and immune thrombocytopenic purpura (ITP) patients. The pharmacodynamics of the drug will be measured as platelet response in patients with ITP.

Description

The Part A of the study is currently not accepting healthy volunteers as the recruitment for the part A has completed.

Details
Condition IDIOPATHIC THROMBOCYTOPENIC PURPURA, Autoimmune disease, Idiopathic Thrombocytopenic Purpura (ITP), Thrombocytopenic
Treatment Placebo, Intravenous immunoglobulin (IVIG), Biological: M254
Clinical Study IdentifierNCT03866577
SponsorMomenta Pharmaceuticals, Inc.
Last Modified on15 August 2021

Similar trials to consider

Loading...

Browse trials for

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer

user name

Added by • 

 • 

Private

Reply by • Private
Loading...

Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!

  The passcode will expire in None.
Loading...

No annotations made yet

Add a private note
  • abc Select a piece of text from the left.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.
Add a private note